113 related articles for article (PubMed ID: 1742932)
1. Prediction of radionuclide bone imaging findings by Gleason histologic grading of prostate carcinoma.
Shih WJ; Mitchell B; Wierzbinski B; Magocum S; Ryo UY
Clin Nucl Med; 1991 Oct; 16(10):763-6. PubMed ID: 1742932
[TBL] [Abstract][Full Text] [Related]
2. The headless bone scan: an uncommon manifestation of metastatic superscan in carcinoma of the prostate.
Massie JD; Sebes JI
Skeletal Radiol; 1988; 17(2):111-3. PubMed ID: 3363378
[TBL] [Abstract][Full Text] [Related]
3. Super bone scan: bone metastases of prostate cancer.
Shikino K; Ikusaka M; Hirota Y; Sato E
BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25228679
[No Abstract] [Full Text] [Related]
4. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
[TBL] [Abstract][Full Text] [Related]
5. Metastatic prostatic pulmonary nodules with normal bone image.
Petras AF; Wollett FC
J Nucl Med; 1983 Nov; 24(11):1026-7. PubMed ID: 6226768
[TBL] [Abstract][Full Text] [Related]
6. Case report: accumulation of 99mTc-hydroxymethylene diphosphonate by liver metastases of prostatic adenocarcinoma.
Mannion RA; Johnson M
Clin Radiol; 1993 Mar; 47(3):209-10. PubMed ID: 8472488
[TBL] [Abstract][Full Text] [Related]
7. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
Pollen JJ; Witztum KF; Ashburn WL
AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
[TBL] [Abstract][Full Text] [Related]
8. Bone metastases are infrequent in patients with newly diagnosed prostate cancer: analysis of their clinical and pathologic features.
Salonia A; Gallina A; Camerota TC; Picchio M; Freschi M; DaPozzo LF; Guazzoni G; Fazio F; Rigatti P; Montorsi F
Urology; 2006 Aug; 68(2):362-6. PubMed ID: 16904453
[TBL] [Abstract][Full Text] [Related]
9. Influence of local tumour stage and grade on reliability of serum prostate-specific antigen in predicting skeletal metastases in patients with adenocarcinoma of the prostate.
Bruwer G; Heyns CF; Allen FJ
Eur Urol; 1999; 35(3):223-7. PubMed ID: 10072624
[TBL] [Abstract][Full Text] [Related]
10. Correlation of prostate-specific antigen and technetium-99m HMDP bone imaging.
Shih WJ; Wierzbinski B; Collins J; Pearson TC; Magoun S; Ryo UY
Clin Nucl Med; 1989 Oct; 14(10):750-5. PubMed ID: 2478331
[TBL] [Abstract][Full Text] [Related]
11. Bone scanning--who needs it among patients with newly diagnosed prostate cancer?
Hirobe M; Takahashi A; Hisasue S; Kitamura H; Kunishima Y; Masumori N; Iwasawa A; Fujimori K; Hasegawa T; Tsukamoto T
Jpn J Clin Oncol; 2007 Oct; 37(10):788-92. PubMed ID: 17911377
[TBL] [Abstract][Full Text] [Related]
12. Bone metastases from poorly differentiated adenocarcinoma of the prostate diagnosed by In-111 ProstaScint (Capromab Pendetide) images with negative results of Tc-99m MDP bone scan and without significant elevation of prostate-specific antigen.
Norris S; Halkar R; Galt J; Petros J; Keller J
Clin Nucl Med; 1999 Nov; 24(11):905-7. PubMed ID: 10551485
[No Abstract] [Full Text] [Related]
13. Prostate cancer in patients from rural and suburban areas--PSA value, Gleason score and presence of metastases in bone scan.
Szot W; Kostkiewicz M; Zając J; Owoc A; Bojar I
Ann Agric Environ Med; 2014; 21(4):888-92. PubMed ID: 25528940
[TBL] [Abstract][Full Text] [Related]
14. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.
Chybowski FM; Keller JJ; Bergstralh EJ; Oesterling JE
J Urol; 1991 Feb; 145(2):313-8. PubMed ID: 1703240
[TBL] [Abstract][Full Text] [Related]
15. When is a bone scan study appropriate in asymptomatic men diagnosed with prostate cancer?
Pal RP; Thiruudaian T; Khan MA
Asian J Androl; 2008 Nov; 10(6):890-5. PubMed ID: 18958353
[TBL] [Abstract][Full Text] [Related]
16. Extensive bone metastases in a patient with prostatic adenocarcinoma and normal serum prostate-specific antigen and prostatic acid phosphatase.
Yuksel M; Cermik TF; Kaya M; Salan A; Ustun F; Salihoglu YS; Yigitbasi ON; Berkarda S
Clin Nucl Med; 2001 Nov; 26(11):962. PubMed ID: 11595863
[No Abstract] [Full Text] [Related]
17. Establishing the pathways and indications for performing isotope bone scans in newly diagnosed intermediate-risk localised prostate cancer - results from a large contemporaneous cohort.
KandaSwamy GV; Bennett A; Narahari K; Hughes O; Rees J; Kynaston H
BJU Int; 2017 Nov; 120(5B):E59-E63. PubMed ID: 28317247
[TBL] [Abstract][Full Text] [Related]
18. [Predictive value of prostate-specific antigen and Gleason sum for results of radionuclide bone scintigraphy in patients with prostate cancer].
Wang TY; Chen XP; Li XS; Jia Yx; Cheng J; Zhang JH; Cai L; Zhang Z; Gong K; He ZS; Zhou LQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):528-34. PubMed ID: 22898839
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of bone scan in patients with metastatic prostate cancer treated initially with androgen deprivation therapy.
Rigaud J; Tiguert R; Le Normand L; Karam G; Glemain P; Buzelin JM; Bouchot O
J Urol; 2002 Oct; 168(4 Pt 1):1423-6. PubMed ID: 12352409
[TBL] [Abstract][Full Text] [Related]
20. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.
Briganti A; Passoni N; Ferrari M; Capitanio U; Suardi N; Gallina A; Da Pozzo LF; Picchio M; Di Girolamo V; Salonia A; Gianolli L; Messa C; Rigatti P; Montorsi F
Eur Urol; 2010 Apr; 57(4):551-8. PubMed ID: 20034730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
